RESEARCH
Russian registry study reports MSI/dMMR prevalence in 2,101 consecutive colorectal cancer patientsA prospective multicenter registry enrolled consecutive, unselected patients with primary colorectal adenocarcinoma at six Moscow centers between 2022 and 2025 to establish population-level data on mismatch repair deficiency prevalence and clinical correlates. (Front Oncol)